- Home
- ALLO vs BTX Comparison
ALLO vs BTX Comparison
Compare ALLO & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLO | BTX |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | 152 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.1M | 770.3M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALLO | BTX |
|---|---|---|
| Price | $2.09 | $8.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $8.35 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 510.9K |
| Earning Date | 05-07-2026 | 11-01-2025 |
| Dividend Yield | N/A | ★ 9.94% |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142,416.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.04 | $6.13 |
| 52 Week High | $4.46 | $9.44 |
Technical Indicators
Market Signals| Indicator | ALLO | BTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.73 | 58.15 |
| Support Level | $2.07 | $8.60 |
| Resistance Level | $2.25 | $9.41 |
| Average True Range (ATR) | 0.11 | 0.20 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 65.85 | 60.35 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About BTX BlackRock Technology and Private Equity Term Trust
BlackRock Technology and Private Equity Term Trust is a closed-end management investment company. Its investment objectives are to provide total return and income through long-term capital appreciation.